Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis.
Beatty WW, Goodkin DE, Monson N, Beatty PA, Hertsgaard D. Beatty WW, et al. Among authors: goodkin de. Arch Neurol. 1988 Jun;45(6):611-9. doi: 10.1001/archneur.1988.00520300029013. Arch Neurol. 1988. PMID: 3369967
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. McDonald WI, et al. Among authors: goodkin d. Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032. Ann Neurol. 2001. PMID: 11456302
Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients.
Blum D, Yonelinas AP, Luks T, Newitt D, Oh J, Lu Y, Nelson S, Goodkin D, Pelletier D. Blum D, et al. Among authors: goodkin d. Brain Cogn. 2002 Oct;50(1):51-61. doi: 10.1016/s0278-2626(02)00009-x. Brain Cogn. 2002. PMID: 12372351
Linkage and association analysis of chromosome 19q13 in multiple sclerosis.
Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL. Pericak-Vance MA, et al. Among authors: goodkin de. Neurogenetics. 2001 Oct;3(4):195-201. doi: 10.1007/s100480100119. Neurogenetics. 2001. PMID: 11714099
Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.
Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Mohr DC, et al. Among authors: goodkin de. Arch Neurol. 2001 Jul;58(7):1081-6. doi: 10.1001/archneur.58.7.1081. Arch Neurol. 2001. PMID: 11448297 Clinical Trial.
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Mohr DC, et al. Among authors: goodkin de. Arch Neurol. 1997 May;54(5):531-3. doi: 10.1001/archneur.1997.00550170015009. Arch Neurol. 1997. PMID: 9152109
Advances in specific therapy for multiple sclerosis.
Jacobs L, Goodkin DE, Rudick RA, Herndon R. Jacobs L, et al. Among authors: goodkin de. Curr Opin Neurol. 1994 Jun;7(3):250-4. doi: 10.1097/00019052-199406000-00012. Curr Opin Neurol. 1994. PMID: 8081519 Review.
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials.
Goodkin DE, Hertsgaard D, Rudick RA. Goodkin DE, et al. Arch Neurol. 1989 Oct;46(10):1107-12. doi: 10.1001/archneur.1989.00520460093019. Arch Neurol. 1989. PMID: 2679508 Clinical Trial.
The efficacy of azathioprine in relapsing-remitting multiple sclerosis.
Goodkin DE, Bailly RC, Teetzen ML, Hertsgaard D, Beatty WW. Goodkin DE, et al. Neurology. 1991 Jan;41(1):20-5. doi: 10.1212/wnl.41.1.20. Neurology. 1991. PMID: 1985289 Clinical Trial.
Diagnostic criteria for multiple sclerosis research involving multiply affected families.
Goodkin DE, Doolittle TH, Hauser SS, Ransohoff RM, Roses AD, Rudick RA. Goodkin DE, et al. Arch Neurol. 1991 Aug;48(8):805-7. doi: 10.1001/archneur.1991.00530200041016. Arch Neurol. 1991. PMID: 1898254
94 results
Jump to page
Feedback